Single-center analysis on a real-world cohort of patients with metastatic urothelial carcinoma studied by NGS: Molecular landscape and efficacy of targeted therapies.

被引：0
|
作者：
Gutierrez Perez, Cesar [1 ]
Rodriguez Ledesma, Inmaculada [1 ]
Pumares Gonzalez, Maria [1 ]
Vela Dominguez, Miriam [1 ]
Espinosa Cabria, Noelia [1 ]
Cabrera Pinos, Maria Liliana [1 ]
Calvo Otero, Laura [1 ]
Valencia Cardenas, Lina Marcela [1 ]
Vina Gopar, Laura [1 ]
Blanco Abad, Carmen [1 ]
Folgueira Hernandez, Benjamin [1 ]
Garcia Munoz, Maria [1 ]
Garcia Giron, Carlos [1 ]
Garcia Toro, Enrique [1 ]
Lastra Aras, Enrique [1 ]
Lopez Peraita, Sandra [1 ]
Ramos Reguera, Irene [1 ]
Saiz Lopez, Patricia [1 ]
de la Torre Lazaro, Sofia [1 ]
Crespo Herrero, Guillermo [1 ]
机构：
[1] Hosp Univ Burgos, Burgos, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183-138-11076; 261-492-3532-2370-7650-2700; 261-566-3525; 261-492-5651-5481; 261-492-5651-9270-5652; 298-4768-3691-2722; 261-566-148; 9; 7; 6; 3; 2; 2080; 2947; 3337; 291; 151; 1; 38092-22447; 38092-23141; 5;
D O I：
10.1200/JCO.2024.42.4_suppl.661
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：661 / 661
页数：1
相关论文
共 50 条
  • [21] Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study
    Isik, Deniz
    Kinikoglu, Oguzcan
    Akdag, Goncagul
    Altintas, Yunus Emre
    Turkoglu, Ezgi
    Yildirim, Sedat
    Surmeli, Heves
    Basoglu, Tugba
    Odabas, Hatice
    Turan, Nedim
    MEDICINA-LITHUANIA, 2024, 60 (07):
  • [22] Real-world costs and outcomes in metastatic renal cell carcinoma patients treated with targeted therapies: a cohort study from the French health insurance database
    Maroun, Rana
    Fleury, Laetitia
    Nachbaur, Gaelle
    Maunoury, Franck
    Vanhille, Jean-Louis
    Durand-Zaleski, Isabelle
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (10) : 1755 - 1762
  • [23] Real-world efficacy of PD-1/PD-L1 inhibitors in patients with advanced pulmonary neuroendocrine carcinoma: a single-center analysis
    Zhai, Wanchen
    Yu, Ying
    Wu, Haicheng
    Zhang, Qian
    Chen, Yunfei
    Yang, Yehao
    Fan, Yun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [24] Hedgehog pathway inhibitors for locally advanced and metastatic basal cell carcinoma: A real-world single-center retrospective review
    Patel, Shivani
    Armbruster, Heather
    Pardo, Gretchen
    Archambeau, Brianna
    Kim, Na Hyun
    Jeter, Joanne
    Wu, Richard
    Kendra, Kari
    Contreras, Carlo M.
    Spaccarelli, Natalie
    Dulmage, Brittany
    Pootrakul, Llana
    Carr, David R.
    Verschraegen, Claire
    PLOS ONE, 2024, 19 (04):
  • [25] Real-world outcomes of targeted therapies and local interventions in BRAF V600E-mutated metastatic colorectal cancer: A single-center retrospective study.
    Lin, Ziqin
    Xie, Xiaoyu
    Zhang, Jianwei
    Hu, Huabin
    Ling, Jiayu
    Cai, Yue
    Wu, Zehua
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 203 - 203
  • [26] Single-center retrospective analysis of safety and efficacy of dose-reduced enfortumab vedotin (EV) in frail patients with metastatic urothelial carcinoma (mUC)
    Song, Wilbur
    Tao, Yu
    Luo, Jingqin
    Roth, Bruce J.
    Reimers, Melissa Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma
    Maruzzo, Marco
    Basso, Umberto
    Diminutto, Alberto
    Roma, Anna
    Zustovich, Fable
    Brunello, Antonella
    Fiduccia, Pasquale
    Banzato, Alberto
    Zattoni, Filiberto
    Zagonel, Vittorina
    FUTURE ONCOLOGY, 2016, 12 (07) : 909 - 919
  • [28] Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma
    Donskov, Frede
    Pinto, Cathy Anne
    Predoiu, Raluca
    Fox, Claire
    Georgsen, Jeanette Baehr
    Skaarup, Katrine
    Burcu, Mehmet
    Perini, Rodolfo
    Steiniche, Torben
    ACTA ONCOLOGICA, 2022, 61 (10) : 1268 - 1277
  • [29] Sequential vs. concurrent systemic therapies in combination with FOLFOX-HAIC for locally advanced hepatocellular carcinoma: a single-center, real-world cohort study
    Sun, Liyang
    Hu, Zhiwen
    Xie, Wa
    Yang, Zhenyun
    Zeng, Huilan
    Zhang, Yaojun
    Chen, Minshan
    Hu, Dandan
    Zhou, Zhongguo
    Pan, Yangxun
    BMC CANCER, 2024, 24 (01)
  • [30] Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study
    Domanski, Piotr
    Pietak, Mateusz
    Kruczyk, Barbara
    Jarosinska, Jadwiga
    Mydlak, Anna
    Demkow, Tomasz
    Darewicz, Marta
    Sikora-Kupis, Bozena
    Dumnicka, Paulina
    Kamzol, Wojciech
    Kucharz, Jakub
    BIOMEDICINES, 2024, 12 (02)
12345